Pfizer profit beats forecast
Pfizer Inc reported a better-than-expected first-quarter profit on Tuesday, as cost-cutting helped offset sharply lower sales of its Lipitor cholesterol fighter and its Chantix smoking-cessation drug.
bdnews24.com News Service
bdnews24.com
Published :
28 Apr 2009, 11:32 AM
Updated :
12 Aug 2022, 01:00 PM
NEW YORK, Tue Apr 28, (bdnews24.com/Reuters) - Pfizer Inc reported a better-than-expected first-quarter profit on Tuesday, as cost-cutting helped offset sharply lower sales of its Lipitor cholesterol fighter and its Chantix smoking-cessation drug.
The world's largest drugmaker earned $2.73 billion, or 40 cents per share. That compared with $2.78 billion, or 41 cents per share, in the year-ago quarter, when Pfizer took acquisition-related charges.
Excluding special items, Pfizer earned 54 cents per share. Analysts on average expected 49 cents per share, according to Reuters Estimates.
Company global revenue fell 8 percent to $10.87 billion, about $180 million below Wall Street expectations. Revenue would have fallen only 3 percent if not for the strengthening dollar, which lowers the value of overseas sales when converted back into US currency.
bdnews24.com/lq/1739.